Calcium channel expression and applicability as targeted therapies in melanoma
- PMID: 25710007
- PMCID: PMC4331404
- DOI: 10.1155/2015/587135
Calcium channel expression and applicability as targeted therapies in melanoma
Erratum in
-
Corrigendum to "Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma".Biomed Res Int. 2016;2016:3017536. doi: 10.1155/2016/3017536. Epub 2016 Aug 17. Biomed Res Int. 2016. PMID: 27610370 Free PMC article.
Abstract
The remodeling of Ca(2+) signaling is a common finding in cancer pathophysiology serving the purpose of facilitating proliferation, migration, or survival of cancer cells subjected to stressful conditions. One particular facet of these adaptive changes is the alteration of Ca(2+) fluxes through the plasma membrane, as described in several studies. In this review, we summarize the current knowledge about the expression of different Ca(2+) channels in the plasma membrane of melanoma cells and its impact on oncogenic Ca(2+) signaling. In the last few years, new molecular components of Ca(2+) influx pathways have been identified in melanoma cells. In addition, new links between Ca(2+) homeostasis and specific cell processes important in melanoma tumor progression have been unveiled. Thus, not only do Ca(2+) channels appear to have a potential as prognostic markers, but their pharmacological blockade or gene silencing is hinted as interesting therapeutic approaches.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
